Recent Advances in Classical Hematology

Indy Hematology Review

R. Brodsky

Bone Marrow Failure: The Importance of Mutational Testing

Rush University Medical Center

J. Shammo

Highlights From ASH 2023 in Bone Marrow Failure Disorders: Aplastic …

Insights from 2023 ASH Annual Meeting

P. Scheinberg

Managing Hematologic irAEs: AIHA, ITP, Bone Marrow Failure, and Thro…

Cleveland Clinic Taussig Cancer Institute

K. McCrae

AA & PNH Case Discussion: 23 y/o Female With PNH With Clonal Regress…

BMFcases

J. Maciejewski, T. Bat

AA & PNH Case Discussion: 53 y/o Male With PNH and Severe AA

BMFcases

J. Maciejewski, T. Bat

Future Perspectives on Aplastic Anemia

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

R. de Latour

The State-of-the-Art in the Care of Aplastic Anemia

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

R. de Latour

Severe Aplastic Anemia: What's on the Horizon?

Johns Hopkins

A. DeZern

Case Presentation: 46 y/o Male With Severe Aplastic Anemia

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

A. Mert Yanık

ASH Annual Meeting Updates in Non-Malignant/Classical Hematology

UChicago Medicine

K. Cohen

Hematology Case Discussion: 71 y/o Female With R/R Aplastic Anemia a…

BMFcases

C. Dunbar, T. Bat

Hematology Case Discussion: 67 y/o Male With Severe Aplastic Anemia …

BMFcases

C. Dunbar, T. Bat

Severe Aplastic Anemia: Current Challenges

Taha Bat

Curative Therapies for Pediatric Acquired Aplastic Anemia

Penn Medicine Cellicon Valley '23: The Future of Cell and Gene Therapies

T. Olson

ASH 2022 New Biological Insights on Clonal Evolution in Aplastic Ane…

ASH 2022 Conference Coverage

A. Kulasekararaj

Importance of Supportive Care in Severe Aplastic Anemia

Phillip Scheinberg

Aplastic Anemia: A Brief Review

Lucio Luzzatto

Immunosuppressive Therapy in Aplastic Anemia

Abhinav Deol

Managing Hematologic Toxicities From Immunotherapeutic Agents

Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies

M. Jaglal